Abstract:Background Microbiota-host interactions are crucial in the progression of inflammatory bowel disease (IBD). Despite extensive research, the detailed mechanisms through which these interactions influence the disease's development and progression remain largely unclear. Understanding these intricate processes is essential for developing targeted therapies and improving patient outcomes. Methods Male C57BL/6 mice were used for all experiments. Enterotoxigenic Bacteroides fragilis (ETBF) was administered orally to induce colitis, while control groups received non-toxigenic Bacteroides fragilis. Both bacterial strains were cultured under anaerobic conditions before gavage. Post-treatment, intestinal tissues were collected, and macrophages were isolated using collagenase digestion followed by magnetic cell sorting (MACS). Total RNA from these macrophages was extracted, and m6A modifications were analyzed via m6A-specific antibodies and high-throughput sequencing. Quantitative reverse transcription PCR (qRT-PCR) and Western blot were employed to measure expression levels of METTL3, FOXD3, ITGA5, and inflammatory markers. The role of FOXD3 in regulating METTL3 transcription was assessed using specific inhibitors or siRNA. Results Here, we reveal that Enterotoxigenic Bacteroides fragilis (ETBF) induces a dramatic reduction of m6A modifications in intestinal inflammatory macrophages, contributing to the initiation of IBD progression. Mechanistically, we characterize B fragilis toxin (BFT), produced by ETBF, which reduces METTL3 transcription by inhibiting FOXD3 expression and promotes the expression of its target integrin subunit alpha 5 (ITGA5) expression by diminishing YTHDF2-dependent mRNA degradation. Targeting ITAG5 using Cilengitide significantly alleviated ETBF-induced colitis by decreasing the level of inflammatory factors in macrophages. Conclusions Our research offers valuable insights into how the gut microbiota modulates the m6A epitranscriptome in human macrophages. This modulation plays a significant role in the progression of inflammatory bowel disease (IBD). By elucidating these complex interactions, our findings contribute to a deeper understanding of IBD pathogenesis and highlight potential avenues for therapeutic intervention.

Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3

The Deubiquitinase OTUD1 Inhibits Colonic Inflammation by Suppressing RIPK1-mediated NF-κB Signaling

Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease.

Olfactomedin-4 Deletion Exacerbates DSS-induced Colitis Through a Matrix Metalloproteinase-9-dependent Mechanism.

Deubiquitinase OTUD6A Regulates Innate Immune Response Via Targeting UBC13

Dysregulated Up-Frameshift Protein 1 Promotes Ulcerative Colitis Pathogenesis Through the TNFR1-NF-κB/MAPKs Pathway

The deubiquitinase OTUD4 inhibits the expression of antimicrobial peptides in Paneth cells to support intestinal inflammation and bacterial infection

Deubiquitinase OTUD6a Drives Cardiac Inflammation and Hypertrophy by Deubiquitination of STING.

Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation

Deubiquitinase USP3 in Macrophages Impaires the Inflammatory Responses in the Colitis Model

P037 USP16-mediated deubiquitination of calcineurin A controls peripheral T cells maintenance and attenuates intestinal inflammation

OTUD5 promotes the inflammatory immune response by enhancing MyD88 oligomerization and Myddosome formation

OTUD1 deubiquitinase regulates NF-κB- and KEAP1-mediated inflammatory responses and reactive oxygen species-associated cell death pathways

The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity

IDDF2024-ABS-0381 Bacteroides Fragilis Toxin Suppresses METTL3-mediated M6a Modification in Macrophage to Promote Inflammatory Bowel Disease

MTDH Promotes Intestinal Inflammation by Positively Regulating TLR Signalling.

The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?

OTULIN protects the intestinal epithelium from apoptosis during inflammation and infection

Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders

Ubiquitin-specific protease 47 regulates intestinal inflammation through deubiquitination of TRAF6 in epithelial cells

ORMDL3 regulates NLRP3 inflammasome activation by maintaining ER-mitochondria contacts in human macrophages and dictates ulcerative colitis patient outcome